Thus, mHAdLyp.sT is more likely to be applicable for future clinical trials as it didn’t induce detectable hepatotoxicity and systemic toxicity but maintained some critical anti-tumor Th1 cytokine response such as IL-12p70 and IFN-γ. The gene discussed is IFNG; the disease is neoplasm.